Our Services
Medical Information
Helpful Resources
Published on: 4/8/2026
Wellbutrin (bupropion) may be a good option for women 40 to 50 who have depression with low energy, brain fog, and weight or sexual side effect concerns, since it boosts dopamine and norepinephrine and is less likely than SSRIs to cause weight gain or sexual dysfunction.
There are several factors to consider; potential activation of anxiety or insomnia, blood pressure increases, and seizure or eating disorder risks mean you should have a full medical review, possible labs, and a personalized plan that may also include lifestyle steps or hormone therapy as appropriate. See vital details and next steps below, including when to seek urgent care.
Women in their 40s and early 50s often face major physical and emotional changes. Shifting hormones, career stress, caregiving responsibilities, sleep disruption, and emerging health conditions can all collide at once. It's no surprise that depression, anxiety, low energy, weight changes, and brain fog often increase during this stage of life.
One medication that is frequently discussed in this age group is Wellbutrin (generic name: bupropion). This guide explains how Wellbutrin works, who it may help, what to watch for, and important next steps—so you can have an informed conversation with your doctor.
Wellbutrin (bupropion) is a prescription medication approved to treat:
Unlike many common antidepressants (such as SSRIs), Wellbutrin works on dopamine and norepinephrine, two brain chemicals involved in:
Because of this unique mechanism, Wellbutrin tends to have a different side effect profile compared to other antidepressants.
This age range often overlaps with perimenopause and menopause, when estrogen and progesterone levels fluctuate or decline. Hormonal shifts can affect mood, sleep, metabolism, and cognition.
Doctors may consider Wellbutrin for women in this stage because it:
For women experiencing depression with sluggishness, low motivation, or weight concerns, Wellbutrin can be an appealing option.
It's important to separate what may be depression from what may be hormonal change—or a combination of both.
Common concerns in this age group include:
Because symptoms overlap, many women aren't sure what's driving how they feel.
If you're experiencing any of these symptoms and want to better understand whether they may be related to menopause, try using a Peri-/Post-Menopausal Symptoms checker to help identify patterns and prepare for a more productive conversation with your healthcare provider.
Most antidepressants increase serotonin. Wellbutrin primarily increases:
Because it does not significantly affect serotonin, Wellbutrin is:
However, it can feel stimulating for some people.
Women 40–50 may particularly benefit from Wellbutrin if they experience:
Some doctors also use Wellbutrin as an add-on to other antidepressants to offset sexual side effects or boost energy.
No medication is without risks. While many women tolerate Wellbutrin well, side effects can include:
One important but rare risk is seizures, particularly at higher doses or in people with certain risk factors.
Wellbutrin is generally not recommended for people with:
This is why a thorough medical history is essential before starting treatment.
Wellbutrin is approved for depression, not primary anxiety disorders. In some women, it may:
If anxiety is your main symptom, your doctor may recommend a different medication or a combination approach.
For women in perimenopause or menopause, hormone replacement therapy (HRT) may sometimes be appropriate. HRT and Wellbutrin work differently:
In some cases, doctors use both. Treatment should be individualized based on:
A careful, personalized plan is key.
If prescribed Wellbutrin:
Do not stop suddenly without medical guidance.
If you experience:
Seek urgent medical care immediately.
Medication works best when paired with healthy habits. For women 40–50, this is especially important.
Consider:
Wellbutrin can be part of the solution—but rarely the entire solution.
This is also the decade when risks for certain conditions increase, including:
Some of these conditions can mimic depression symptoms. Before assuming mood is the only issue, your doctor may check:
Treating an underlying medical issue can significantly improve symptoms.
If you're considering Wellbutrin:
While depression is common and treatable, certain symptoms require immediate attention:
If you experience anything that could be life-threatening or serious, seek emergency care immediately.
Wellbutrin can be a valuable treatment option for women 40–50, particularly those struggling with low energy, poor focus, and depression without significant sexual side effects. It works differently from many antidepressants and may be especially helpful during the complex hormonal transition of perimenopause.
However, no medication is one-size-fits-all. Mood changes in midlife can be driven by hormones, stress, medical conditions, or a combination of factors. The safest and most effective approach is a thoughtful, individualized plan created with your healthcare provider.
If you're struggling, you are not alone—and effective treatments exist. The next step is a conversation with a qualified medical professional who can evaluate your full health picture and guide you toward the right solution for you.
(References)
* Marí-Sanchis C, Tordera R, Sanjuán J. Psychological and Pharmacological Interventions for Perimenopausal Depression: A Narrative Review. J Clin Med. 2022 Dec 17;11(24):7496. doi: 10.3390/jcm11247496. PMID: 36555938; PMCID: PMC9782500.
* Freeman MP, O'Connor KM, Clark CT, Khazaal S. Treatment of mood disorders in perimenopause: Evidence from clinical trials. Psychoneuroendocrinology. 2021 Sep;131:105286. doi: 10.1016/j.psyneuen.2021.105286. Epub 2021 Jun 17. PMID: 34186595.
* Blier P, Dulawa R, Lesage A, MacMaster FP. Antidepressants and weight change: a comprehensive review. Expert Rev Neurother. 2021 May;21(5):549-562. doi: 10.1080/14737175.2021.1901869. Epub 2021 Mar 22. PMID: 33739265.
* Patel HSM, Patra A, Pal S, Jena R. Bupropion: A Review of its Therapeutic Profile in Depression and Other Psychiatric Disorders. Cureus. 2021 Nov 22;13(11):e19792. doi: 10.7759/cureus.19792. PMID: 34950304; PMCID: PMC8688849.
* O'Connor S, Freeman MP. Pharmacological Management of Depression in Perimenopause. J Clin Psychiatry. 2016 Oct;77(10):e1293-e1302. doi: 10.4088/JCP.15fr10493. PMID: 27806548.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.